Isoray - Innovative Brachytherapy

Management Team

Lori Woods - CEO

Lori A. Woods

Chief Executive Officer
& Member of the Board of Directors

William A. Cavanagh, III

William A. Cavanagh, III

Chief Research & Development Officer

Jonathan Hunt

Chief Financial Officer

Jennifer Streeter

Chief Operating Officer
& Vice President of Human Resources

Mark Austin

Controller & Corporate Secretary

Lori Woods

Chief Executive Officer & Member of the Board of Directors

Lori Woods brings more than 30 years of experience in the healthcare industry and is particularly well-known and respected in the brachytherapy community.  Ms. Woods returns to IsoRay after previously serving as Vice President from 2006 to February 2008 at which time she was appointed Acting Chief Operating Officer before her appointment to Chief Operating Officer in February 2009, a position which she served until January 2010.  During her previous engagement with the company, Ms. Woods played an instrumental role in streamlining manufacturing operations, reducing supply costs and establishing initial reimbursement rates for Cesium-131. She also initiated a clinical research department to ensure that the company was continually working to leverage maturing clinical data through peer-reviewed publications, podium presentations, clinical advisory boards, physician training and other company-sponsored initiatives.  In addition, she was involved in working with institutional investors on a $20 million capital raise for IsoRay. Beginning in February 2016, and continuing until her appointment as Interim CEO, Ms. Woods served as a senior consultant to IsoRay.

Most recently, Ms. Woods was a Principal of Medvio, LLC, a medical device consulting company focused on the urology and oncology space.  During her time at Medvio she worked with large public and international medical device companies, supporting the approval process and distribution of products in diverse international markets.  Further, she worked with various partners to develop proprietary technologies for the colo-rectal and liver treatment markets.

Previously, Ms. Woods served as Chief Executive Officer of Pro-Qura, Inc., a privately-owned cancer treatment management company focused on the quality delivery of brachytherapy treatments for prostate cancer.  She has also served as the Director of Business Development for the Tumor Institute Radiation Oncology Group and the Seattle Prostate Institute (SPI) in Seattle, WA. SPI was an early innovator in prostate brachytherapy treatments and assisted in the training of more than 2,000 physicians in the use of prostate brachytherapy.  During that time, Ms. Woods worked to secure long-term, independent reimbursement for brachytherapy seeds and coverage from CMS and private carriers.

Until recently, Ms. Woods served as a board member of the Northwest division of the Juvenile Diabetes Research Foundation, focusing on their digital awareness programs, including their website and SEO strategy, and their public relations efforts.  Ms. Woods earned a Bachelor of Science degree in Business Administration – Marketing and Communications from Loma Linda University, CA.

William A. Cavanagh, III

Chief Research & Development Officer

William Cavanagh, III served the Company as Chief Operating Officer and Chief Scientific Officer from February 2016 to January 2019, Interim Chief Executive Officer from January to February 2016, and Vice-President of Research and Development from January 2010 to January 2016.

Mr. Cavanagh began his extensive career in cancer treatment technologies in the early 1990s, when he helped head research and development of a therapy involving the insertion of radioactive sources directly into the prostate for the treatment of prostate cancer (prostate brachytherapy). He has designed several cancer treatment-related studies, is listed as an author on 34 peer-reviewed publications, and is the listed inventor on a U.S. patent application detailing a novel treatment for cancer.

Mr. Cavanagh has also served as Director of the Haakon Ragde Foundation for Advanced Cancer Studies in Seattle, Washington, where he lead the research foundation in the selection of viable research projects directed at treating advanced cancers.

Jonathan Hunt

Chief Financial Officer

Jonathan Hunt has more than 25 years of finance and accounting experience excelling as a versatile leader with a successful track record in turnarounds, startups, mergers, divestitures, growth strategies, performance and operations management and analysis at a number of organizations, including Fortune 500 companies.

Before joining IsoRay, Hunt was Chief Financial Officer at Vivid Learning Systems, where he had a central role in the company’s turnaround, that included growing revenues and implementing financial policy and process changes that ultimately resulted in the successful sale of the company. In addition to his prior experience at IsoRay, where he was Chief Financial Officer from 2006 to 2009, Hunt worked with Hypercom Corporation, a global provider of electronic payment solutions and manufacturer of credit card terminals, where he served as Assistant Corporate Controller from 2005 to 2006. His financial background also includes positions as a Manager and Director of Financial Reporting and Director of Operational Planning and Analysis for ConocoPhillips and Circle K Corporation and its affiliates from 2000 to 2005 and his work for PricewaterhouseCoopers LLP from 1992 to 1999, where his last position held was Business Assurance Manager.

Jennifer Streeter

Chief Operating Officer & Vice President of Human Resources

Mrs. Streeter brings more than 20 years’ experience of progressive growth in leading teams across multiple industries in many different capacities

July 2019 Mrs. Streeter accepted the role of Interim COO to further support the organization in an operational capacity leveraging her strategic and leadership abilities. She is focused on manufacturing scale and future growth

In September 2016, she accepted responsibility for the Human Resources department focused on staffing models and performance management

Prior to joining Isoray, Mrs. Streeter was employed by SuperShuttle International as the Vice President of Learning Development where she led a team providing overall training and organizational development activities

Mark Austin

Controller & Corporate Secretary

Mark Austin has served as Controller, Principal Financial and Accounting Officer, since July 2017. Prior to joining the Company, Mr. Austin, served as a Senior Manager and before that, as a Manager and Senior Associate at KPMG in Portland, Oregon, since 2009, where he served as lead for financial statement and internal control audits within the technology industry, including for software and manufacturing companies. While at KPMG, Mr. Austin served as lead manager for a global public company; supervised, coached, and lead teams and team members; and researched technical accounting issues relevant to the technology industry. Mr. Austin holds a Bachelor of Science in Commerce degree in Accounting, from Santa Clara University, in Santa Clara, California.

Board of Directors

To view our Board of Directors in more detail, visit our Governance section in our Investor Center.

Michael McCormick

Chairman of the Board

Alan Hoffmann

 

Dr. Philip Vitale

 

Lori Woods - CEO

Lori A. Woods

Chief Executive Officer
& Member of the Board of Directors